Advertisement · 728 × 90
#
Hashtag
#NanoViricides
Advertisement · 728 × 90
Zacks Small Cap Research
Zacks Small Cap Research
@zackssmallcap.bsky.social
5 months ago
NNVC: Phase 2 Trial of NV-387 Antiviral for Mpox | NanoViricides
NNVC: Phase 2 Trial of NV-387 Antiviral for Mpox | NanoViricides YouTube video by Zacks Investment Awareness

#NNVC NanoViricides is preparing for a Phase 2 trial of NV-387 for Mpox, expected to begin in late 2025 or early 2026. Results could set the stage for stockpile programs and broader antiviral use. #NanoViricides #BiotechStocks #Antivirals

youtu.be/7bJAJ82Dltc

0 0 1 0
Zacks Small Cap Research
Zacks Small Cap Research
@zackssmallcap.bsky.social
8 months ago
NNVC: NanoViricides Set to Initiate Phase 2 Trial in MPox
NNVC: NanoViricides Set to Initiate Phase 2 Trial in MPox YouTube video by Zacks Investment Awareness

A new antiviral class. A Phase 2 trial for deadly Mpox Clade I. A platform with multi-virus potential. #NNVC is one to watch.

youtu.be/ZvLpA9p8h9M

#NanoViricides #Biotech #SmallCapStocks #Antivirals #ClinicalTrials #Mpox #HealthcareInnovation

0 0 1 0